Strategies for vascularization of polymer scaffolds

Journal of Investigative Medicine

Volumn 58, Issue 7, 2010, Pages 838-844

  Papavasiliou, Georgia ^a   Ming Huei, Cheng ^b   Brey, Eric M ^a,c  

^a Illinois Institute of Technology   (United States)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c HINES VA HOSPITAL   (United States)

Author keywords

Engineered tissues; Growth factors; Polymers; Vascularization; Wound healing

Indexed keywords

BIOMATERIAL; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MACROGOL; POLYMER; VASCULOTROPIN;

CELL FUNCTION; CELL MIGRATION; CELL STRUCTURE; CELL SURVIVAL; CLINICAL RESEARCH; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; MICROCIRCULATION; SURGICAL APPROACH; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULARIZATION; ARTICLE; NEOVASCULARIZATION (PATHOLOGY); POLYMERIZATION; TISSUE SCAFFOLD;

EID: 78651518437     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181f18e38     Document Type: Conference Paper

References (60)

1. MacNeil S. Progress and opportunities for tissue-engineered skin. Nature. 2007;445(7130):874-880.
2. Nikol S, Baumgartner I, Van Belle E, et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther. 2008;16(5):972-978.
3. Ozawa CR, Banfi A, Glazer NL, et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest. 2004;113(4):516-527.
4. Dvorak HF, Detmar M, Claffey KP, et al. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995;107(1-3): 233-235.
5. Seliktar D, Zisch AH, Lutolf MP, et al. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A. 2004;68(4):704-716.
6. Ehrbar M, Metters A, Zammaretti P, et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release. 2005;101(1-3): 93-109.
7. Moya ML, Garfinkel MR, Liu X, et al. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J Surg Res. 2010;160(2):208-212.
8. Moya ML, Lucas S, Francis-Sedlak M, et al. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvasc Res. 2009;78(2):142-147.
9. Moya ML, Cheng MH, Huang JJ, et al. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials. 2010;31(10):2816-2826.
10. Uriel S, Brey EM, Greisler HP. Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation. Am J Surg. 2006;192(5):604-609.
11. Peirce SM, Price RJ, Skalak TC. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol. 2004;286(3):H918-H925.
12. Cao R, Brakenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med. 2003;9(5):604-613.
13. Richardson TP, Peters MC, Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19(11):1029-1034.
14. Khanna O, Moya ML, Opara EC, et al. Synthesis of multilayered alginate microcapsules for the sustained-release of fibroblast growth factor-1. J Biomed Mater Res. In press.
15. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161(6):1163-1177.
16. Barkefors I, Le Jan S, Jakobsson L, et al. Endothelial cell migration in stable gradients of vascular endothelial growth factor a and fibroblast growth factor 2-effects on chemotaxis and chemokinesis. J Biol Chem. 2008;283(20):13095-13912.
17. Liu L, Ratner BD, Sage EH, et al. Endothelial cell migration on surface-density gradients of fibronectin, VEGF, or both proteins. Langmuir. 2007;23(22):11168-11173.
18. DeLong SA, Moon JJ, West JL. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials. 2005;26(16):3227-3234.
19. Chung S, Sudo R, Mack PJ, et al. Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip. 2009;9(2):269-275.
20. Chung S, Sudo R, Vickerman V, et al. Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell interactions. Ann Biomed Eng. 2010;38(3):1164-1177.
21. Chung S, Sudo R, Zervantonakis IK, et al. Surface-treatment-induced three-dimensional capillary morphogenesis in a microfluidic platform. Adv Mater. 2009;21(47):4863-4867.
22. Vickerman V, Blundo J, Chung S, et al. Design, fabrication and implementation of a novel multi-parameter control microfluidic platform for three-dimensional cell culture and real-time imaging. Lab Chip. 2008;8(9):1468-1477.
23. Brey EM, Uriel S, Greisler HP, et al. Therapeutic neovascularization: contributions from bioengineering. Tissue Eng. 2005;11(3-4): 567-584.
24. Nor JE, Peters MC, Christensen JB, et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest. 2001;81(4):453-463.
25. Nor JE, Christensen J, Liu J, et al. Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res. 2001;61(5):2183-2188.
26. Brey EM, Greisler HP. Telomerase expression in somatic cells. Lancet. 2005;365(9477):2068-2069.
27. Poh M, Boyer M, Solan A, et al. Blood vessels engineered from human cells. Lancet. 2005;365(9477):2122-2124.
28. Levenberg S, Golub JS, Amit M, et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2002;99(7):4391-4396.
29. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23(7):879-884.
30. Ghajar CM, Blevins KS, Hughes CC, et al. Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng. 2006;12(10):2875-2888.
31. Koike N, Fukumura D, Gralla O, et al. Tissue engineering: creation of long-lasting blood vessels. Nature. 2004;428(6979):138-139.
32. Chen X, Aledia AS, Ghajar CM, et al. Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A. 2009;15(6):1363-1371.
33. Chen CS, Mrksich M, Huang S, et al. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog. 1998;14(3):356-363.
34. Dike LE, Chen CS, Mrksich M, et al. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell Dev Biol Anim. 1999;35(8):441-448.
35. Kaihara S, Borenstein J, Koka R, et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 2000;6(2):105-117.
36. Borenstein JT, Weinberg EJ, Orrick BK, et al. Microfabrication of three-dimensional engineered scaffolds. Tissue Eng. 2007;3(8):1837-1844.
37. Griffith LG, Wu B, Cima MJ, et al. In vitro organogenesis of liver tissue. Ann N y Acad Sci. 1997;831:382-397.
38. King KR, Wang CCJ, Kaazempur-Mofrad MR, et al. Biodegradable microfluidics. Adv Mater. 2004;16(2):2007-2012.
39. Fidkowski C, Kaazempur-Mofrad MR, Borenstein J, et al. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng. 2005;11(1-2): 302-309.
40. Chrobak KM, Potter DR, Tien J. Formation of perfused, functional microvascular tubes in vitro. Microvasc Res. 2006;71(3):185-196.
41. Nahmias Y, Schwartz RE, Verfaillie CM, et al. Laser-guided direct writing for three-dimensional tissue engineering. Biotechnol Bioeng. 2005;92(2):129-136.
42. Chen CY, Barron JA, Ringeisen BR. Cell patterning without chemical surface modification: cell-cell interactions between printed bovine aortic endothelial cells (BAEC) on a homogeneous cell-adherent hydrogel. Appl Surf Sci. 2006;252(24):8641-8645.
43. Papavasiliou G, Songprawat P, Perez-Luna VH, et al. Three-dimensional patterning of poly (ethylene glycol) hydrogels through surface-initiated photopolymerization. Tissue Eng Part C Methods. 2008;14(2):129-140.
44. Chiu YC, Larson JC, Perez-Luna VH, et al. Formation of microchannels in poly (ethylene glycol) hydrogels by selective degradation of patterned microstructures. Chem Mater. 2009;21(8):1667-1682.
45. Uriel S, Huang JJ, Moya ML, et al. The role of adipose protein derived hydrogels in adipogenesis. Biomaterials. 2008;29(27):3712-3719.
46. Cheng MH, Brey EM, Allori A, et al. Ovine model for engineering bone segments. Tissue Eng. 2005;11(1-2): 214-225.
47. Cheng MH, Brey EM, Allori AC, et al. Periosteum-guided prefabrication of vascularized bone of clinical shape and volume. Plast Reconstr Surg. 2009;124(3):787-795.
48. Cheng MH, Brey EM, Ulusal BG, et al. Mandible augmentation for osseointegrated implants using tissue engineering strategies. Plast Reconstr Surg. 2006;118(1):1e-4e.
49. Cheng MH, Uriel S, Moya ML, et al. Dermis-derived hydrogels support adipogenesis in vivo. J Biomed Mater Res. 2010;92(3):852-858.
50. Brey EM, Cheng MH, Allori A, et al. Comparison of guided bone formation from periosteum and muscle fascia. Plast Reconstr Surg. 2007;119(4):1216-1222.
51. Hofer SO, Knight KM, Cooper-White JJ, et al. Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast Reconstr Surg. 2003;111(3):1186-1192; discussion 1193-1194.
52. Mian R, Morrison WA, Hurley JV, et al. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng. 2000;6(6):595-603.
53. Mian RA, Knight KR, Penington AJ, et al. Stimulating effect of an arteriovenous shunt on the in vivo growth of isografted fibroblasts: a preliminary report. Tissue Eng. 2001;7(1):73-80.
54. Tanaka Y, Sung KC, Tsutsumi A, et al. Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation? Plast Reconstr Surg. 2003;112(6):1636-1644.
55. Staudenmaier R, Hoang TN, Kleinsasser N, et al. Flap prefabrication and prelamination with tissue-engineered cartilage. J Reconstr Microsurg. 2004;20(7):555-564. (Pubitemid 39458727)
56. Demirtas Y, Engin MS, Aslan O, et al. The effect of "minimally invasive transfer of angiosomes" on vascularization of prefabricated/ prelaminated tissues. Ann Plast Surg. 2010;64(4):491-495.
57. Guo L, Pribaz JJ. Clinical flap prefabrication. Plast Reconstr Surg. 2009;24(6 suppl): e340-e350.
58. Mathy JA, Pribaz JJ. Prefabrication and prelamination applications in current aesthetic facial reconstruction. Clin Plast Surg. 2009;36(3):493-505.
59. Pribaz JJ, Fine NA. Prefabricated and prelaminated flaps for head and neck reconstruction. Clin Plast Surg. 2001;28(2):261-272, vii.
60. Francis-Sedlak ME, Moya ML, Huang JJ, et al. Collagen glycation alters neovascularization in vitro and in vivo. Microvasc Res. 2010;80(1):3-9.